Evidence map›Paper›PMID 27717390›Full record

ArticleRespiratory research2016

Perip7lakin is a target for autoimmunity in asthma.

Camille Taillé, Sabine Grootenboer-Mignot, Candice Estellat, Carine Roy, Sophie Ly Ka So, Marina Pretolani, Michel Aubier, Bruno Crestani, Sylvie Chollet-Martin

Open access · goldAbstract readLetter
In one paragraph

Article in Respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Autoallergy and what the Allergist Needs to know.Current allergy and asthma reports · 2025
    Review
  3. Autoimmunity: A New Focus on Nasal Polyps.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Autoimmune Responses in Severe Asthma.Allergy, asthma & immunology research · 2018
    Review
  7. Review
  8. Article
  9. Eosinophils in Autoimmune Diseases.Frontiers in immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Camille TailléAssistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares, Paris, France. camille.taille@aphp.fr.ORCID 0000-0001-9768-5728
Sabine Grootenboer-MignotAssistance publique-Hôpitaux de Paris, Hôpital Bichat, Laboratoire d'immunologie « Autoimmunité et Hypersensibilités », Paris, France.
Candice EstellatAssistance Publique-Hôpitaux de Paris, Hôpital Bichat, Unité de recherche clinique, département de biostatistiques, Paris, France.
Carine RoyAssistance Publique-Hôpitaux de Paris, Hôpital Bichat, Unité de recherche clinique, département de biostatistiques, Paris, France.
Sophie Ly Ka SoAssistance publique-Hôpitaux de Paris, Hôpital Bichat, Laboratoire d'immunologie « Autoimmunité et Hypersensibilités », Paris, France.
Marina PretolaniInserm UMR 1152, LabEx Inflamex, Paris, France.
Michel AubierAssistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares, Paris, France.
Bruno CrestaniAssistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares, Paris, France.
Sylvie Chollet-MartinAssistance publique-Hôpitaux de Paris, Hôpital Bichat, Laboratoire d'immunologie « Autoimmunité et Hypersensibilités », Paris, France.
Assistance Publique – Hôpitaux de Paris · FRInserm · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of autoimmunity targeting epithelial antigens in asthma has been suggested, in particular in non-atopic and severe asthma. Periplakin, a desmosomal component, is involved in epithelial cohesion and intracellular signaling. We detected anti-periplakin IgG antibodies in 47/260 (18 %) patients with asthma, with no association with severity or atopy. In addition, anti-periplakin IgE antibodies were detected in 12 of 138 tested patients (8.7 %) and were more frequently observed in patients with than without nasal polyposis. This study identifies a new autoimmune epithelial target in asthma. Whether periplakin autoimmunity (both IgG and IgE auto-antibodies) is involved in asthma pathogenesis remains to be studied during the disease course of these patients.

Indexed as

AutoimmunityAdultAsthmaAutoantibodiesBiomarkersCase-Control StudiesFemaleFranceHumansImmunoglobulin EImmunoglobulin GMaleMiddle AgedNasal PolypsPlakinsPrevalenceAutoantibodiesBiomarkersImmunoglobulin EImmunoglobulin GPlakinsPPL protein, humanAirway epitheliumAsthmaAutoimmunityDesmosomeNasal polyposis

Identifiers

PMID27717390
PMCPMC5054582
OpenAlexW2527874171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.